Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 9, No 1 (2017) The genetic basis of Parkinson's disease Abstract  similar documents
A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, P. I. Gurieva, N. A. Shnaider, M. M. Petrova, M. R. Sapronova
"... Parkinson's disease (PD) is a multifactorial disease that develops in the presence of both genetic ..."
 
Vol 6, No 4 (2014) The epidemiological, clinical, and genetic characteristics of Parkinson’s disease (in case of Zheleznogorsk) Abstract  similar documents
M. R. Sapronova, N. A. Shnaider
"... Parkinson’s disease (PD) is the second most common human neurodegenerative disorder. Genetically ..."
 
Vol 10, No 4 (2018) Sporadic cerebral non-amyloid microangiopathy: pathogenesis, diagnosis, and features of treatment policy Abstract  similar documents
A. A. Kulesh, V. E. Drobakha, V. V. Shestakov
"... The paper is devoted to the most common variant of cerebral small-vessel disease Р sporadic ..."
 
Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания Cerebral small vessel disease: classification, clinical manifestations, diagnosis, and features of treatment Abstract  similar documents
A. A. Kulesh, V. E. Drobakha, V. V. Shestakov
"... of the disease. Sporadic non-amyloid microangiopathy, cerebral amyloid angiopathy, and cerebral autosomal ..."
 
Vol 9, No 4 (2017) Neuropsychological pattern of Parkinson's disease Abstract  similar documents
A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, N. A. Schnaider, M. M. Petrova, M. R. Sapronova
"... The review deals with the problem of neuropsychological disorders in Parkinson's disease (PD), one ..."
 
Vol 10, No 2 (2018) Parkinson's disease and polymorphisms of the glutamatergic system genes GRIN2A, SLC1A2, and GRIK4 Abstract  similar documents
Yu. S. Mironova, I. A. Zhukova, N. G. Zhukova, S. A. Ivanova, V. M. Alifirova, A. S. Boiko, D. Z. Osmanova, O. P. Izhboldina, A. V. Latypova
"... Parkinson's disease (PD) is now increasingly considered as a multi-system disorder associated ..."
 
Vol 6, No 4 (2014) The development and treatment of Alzheimer’s disease: Some genetic aspects Abstract  similar documents
I. S. Preobrazhenskaya, N. S. Snitskaya
"... . The reason for its higher incidence rate is the specific features of the current information sphere. Genetic ..."
 
Vol 11, No 3 (2019) Mitochondrial genome and risk of multiple sclerosis Abstract  similar documents
A. N. Boyko, M. S. Kozin, G. Zh. Osmak, O. G. Kulakova, O. O. Favorova
"... Mitochondrial DNA (mtDNA) polymorphism makes a certain contribution to the formation of a genetic ..."
 
Vol 6, No 1S (2014): Special issue "Epilepsy" Genetics of Epilepsy: What for and How to Examine Children with Epilepsy E.D. Belousova Abstract  similar documents
E. D. Belousova
"... The paper focuses on problems of genetic examination of children with epilepsy. The major types ..."
 
Vol 11, No 4 (2019) Genetic risk factors for behavioral adverse reactions in epileptic patients taking levetiracetam Abstract  similar documents
A. A. Usoltseva, D. V. Dmitrenko, S. N. Zobova, E. N. Bochanova, N. A. Shnayder
"... ARs. Objective: to establish genetic risk factors for behavioral ADRs in epileptic patients taking ..."
 
Vol 8, No 4 (2016) GENETIC AND FUNCTIONAL FACTORS IN THE DEVELOPMENT OF COGNITIVE IMPAIRMENT IN HYPERTENSION: A PROSPECTIVE STUDY Abstract  similar documents
Yu. V. Zhitkova, A. A. Gasparyan, D. R. Khasanova, N. R. Khasanov, V. N. Oslopov
"... различных сосудистых бассейнах. Выявлена взаимосвязь показателя ЦВР с генетически детерминированным уровнем ..."
 
Vol 10, No 4 (2018) Use of valproate and carbamazepine in the therapy of epilepsy (guidelines for the practitioner) Abstract  similar documents
P. N. Vlasov
 
Online-first GENETIC RISK FACTORS FOR THE DEVELOPMENT OF BEHAVIORAL ADVERSE DRUG REACTIONS IN PATIENTS WITH EPILEPSY TAKING LEVETIRACETAM Abstract  similar documents
A. A. Usoltseva, D. V. Dmitrenko, S. N. Zobova, E. N. Bochanova, N. A. Shnayder
"... of LEV-induced ADR. Purpose: To determine the genetic risk factors for the development of behavioral ADR ..."
 
Vol 11, No 2 (2019) Tobacco smoking dependence in patients with depressive spectrum mental disorders: clinical, pathogenetic, and therapeutic aspects Abstract  similar documents
O. I. Speranskaya, S. A. Trushchelev, Z. I. Storozheva
"... established to be to a large extent determined by their common genetic bases. This association substantially ..."
 
Vol 5, No 4 (2013) A case of Niemann – Pick disease type C Abstract  similar documents
Sergei Anatolyevich Klyushnikov, O R Smirnov, E Yu Zakharova
"... diagnostic verification, including molecular genetic testing, are presented. Information is given on specific ..."
 
Vol 4, No 1 (2012) Sustained-release pramipexole in the treatment of Parkinson’s disease Abstract  similar documents
Natalia Vladimirovna Fedorova
"... for dopaminergic deficiency in Parkinson’s disease (PD). Since 1996, pramipexole has been used to treat early ..."
 
Vol 5, No 1 (2013) Dopamine dysregulation syndrome in Parkinson’s disease Abstract  similar documents
A V Nikitina, Natalia Vladimirovna Fedorova
"... therapy. According to the data available in the literature, DDS develops in 3-4% of the Parkinson’s ..."
 
Vol 8, No 4 (2016) HYPERSOMNIA AND CIRCADIAN DISTURBANCES IN PARKINSON’S DISEASE Abstract  similar documents
M. R. Nodel
"... studied symptoms of Parkinson’s disease (PD). It manifests as constant excessive sleepiness during the day ..."
 
Vol 8, No 4 (2016) INTERMEDIATE PHENOTYPES OF OBSTRUCTIVE SLEEP APNEA/HYPOPNEA SYNDROME Abstract  similar documents
N. A. Shnayder, M. M. Petrova, I. V. Demko, O. V. Alekseeva
"... phenotypes of OSAHS, in the development of which there may be a genetic component. It is stated that a study ..."
 
Vol 5, No 2 (2013) Current possibilities of therapy for sleep disorders in Parkinson’s disease Abstract  similar documents
Marina Romanovna Nodel
"... and awakening disorders in patients with Parkinson's disease (PD). It covers the current views of the role ..."
 
Vol 6, No 1 (2014) Apathy in Parkinson's disease patients Abstract  similar documents
M. R. Nodel
"... pathy in Parkinson's disease (PD) patients is one of the least studied manifestations of a broad ..."
 
Vol 2, No 4 (2010) Depression in Parkinson's disease Abstract  similar documents
M. R. Nodel'
"... Parkinson's disease (PD) is a multisystemic neurodegenerative disease with a wide spectrum ..."
 
Vol 6, No 3 (2014) Current therapy for Parkinson's disease Abstract  similar documents
A. V. Obukhova
"... The main goal of therapy for Parkinson's disease (PD) is to correct dopamine deficiency ..."
 
Vol 3, No 1 (2011) Sleep disorders in Parkinson's disease Abstract  similar documents
M. R. Nodel
"... of Parkinson's disease (PD). Objective: to specify the clinical features of sleep disorders in patients ..."
 
Online-first Features of pathogenesis and clinical manifestation of Parkinson's disease developed from essential tremor Abstract  similar documents
A. V. Kudrevatykh, I. V. Miliukhina
"... In last decades, there is evidence of the relationship of Parkinson's disease (PD) and essential ..."
 
Vol 11, No 2 (2019) Pathogenesis, clinical features, and treatments of depression in Parkinson's disease Abstract  similar documents
I. V. Milyukhina
"... Depression is the most common non-motor manifestation of Parkinson's disease (PD), which ..."
 
Vol 3, No 4 (2011) Parkinson's disease fatigability and its correction with the dopamine receptor agonist pramipexole Abstract  similar documents
M. R. Nodel
"... Fatigability is a common nonmotor symptom in Parkinson's disease (PD), which worsens quality ..."
 
Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY A clinical case of epilepsy in a female patient with double mutations in the SCN2A and PCDH19 genes Abstract  similar documents
M. B. Mironov, M. Yu. Bobylova, S. G. Burd, T. M. Krasilshchikova, M. M. Gunchenko, M. N. Sarzhina, T. T. Batysheva
 
Vol 8, No 3 (2016) A clinical case of adult onset Niemann–Pick disease type C Abstract  similar documents
E. V. Saifullina, R. V. Magzhanov, A. K. Mardanova, T. Yu. Proshlyakova, E. Yu. Zakharova, S. A. Klyushnikov, S. N. Illarioshkin
 
Vol 4, No 2 (2012) Strokes in mitochondrial diseases Abstract  similar documents
N V Pizova
"... and ragged-red fibers (MERRF) syndrome, and Kearns-Sayre syndrome (sporadic multisystem mitochondrial ..."
 
Vol 4, No 1 (2012) Sleep and awakening disorders in Parkinson’s disease: comprehensive approach to therapy Abstract  similar documents
Marina Romanovna Nodel
"... and awakening disorders in patients with Parkinson’s disease (PD). It covers the current views of the role ..."
 
Vol 4, No 2 (2012) Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease Abstract  similar documents
S N Illarioshkin
"... receptor agonists (DRA) remains the leading pharmacotherapeutic strategy for Parkinson’s disease (PD ..."
 
Vol 6, No 4 (2014) Nondrug therapy in the combination rehabilitation of patients with Parkinson’s disease Abstract  similar documents
V. L. Golubev, A. B. Kamakinova
"... Non-drug rehabilitation in Parkinson’s disease (PD) has recently attracted the increasing ..."
 
Vol 9, No 4 (2017) Sleep disorders in Parkinson’s disease: approaches to treatment and prevention Abstract  similar documents
M. R. Nodel, G. V. Kovrov
"... Nocturnal sleep disorders are one of the most important non-motor manifestations of Parkinson’s ..."
 
Vol 2, No 3 (2010) Treatment of parkinson's disease at a young age Abstract  similar documents
D. V. Artemyev
"... and middle-aged patients. It is stressed that early-onset Parkinson's disease (PD) shows a number ..."
 
Vol 1, No 2 (2009) NERVOUS AND MENTAL DISORDERS OF PARKINSON'S DISEASE Abstract  similar documents
M. R. Nodel', N. N. Yakhno
"... Parkinson's disease (PD) is a multisystemic neurodegenerative disease involving different mediator ..."
 
Vol 5, No 2 (2013) The clinical picture of early-stage Parkinson’s disease. errors in the diagnosis of different forms Abstract  similar documents
E N Gubanova, Natalia Vladimirovna Fedorova
"... The paper describes the clinical picture of Parkinson’s disease (PD), by indicating its stages ..."
 
Vol 5, No 1 (2013) Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease Abstract  similar documents
Oleg Semenovich Levin, V K Datiyeva
"... receptor agonist (DRAs), which has been widely used to treat Parkinson’s disease (PD) in foreign countries ..."
 
Vol 5, No 2 (2013) Neuropsychological syndromes in patients with Parkinson’s disease after deep electric stimulation of pallidar complex structures Abstract  similar documents
Yu V Mikadze, Irina Igorevna Titkova, A O Gushcha, V M Tyurnikov
"... The paper provides the results of neuropsychological examinations in 10 patients with Parkinson’s ..."
 
Vol 4, No 3 (2012) Clinical experience with requip modutab Abstract  similar documents
Denis Valeryevich Zakharov, V A Mikhailov
"... of therapy for extensive-stage Parkinson’s disease (PD) and to correct motor fluctuations and drug-induced ..."
 
Vol 9, No 1 (2017) The clinical features, diagnosis, and treatment of cognitive impairments in Parkinson's disease Abstract  similar documents
G. N. Akhmadeeva, R. V. Magzhanov, G. N. Tayupova, A. R. Baitimerov
"... with Parkinson's disease (PD) and gives their characteristics and epidemiology, the specific features ..."
 
Vol 5, No 3 (2013) The efficacy of the dopamine agonist Rotigotine in the treatment of Parkinson's disease Abstract  similar documents
Marina Romanovna Nodel
"... patch in Parkinson's disease (PD) and discusses the results of clinical trials of Rotigotine in early ..."
 
Vol 7, No 3 (2015) Experience in using levodopa-benserazide Abstract  similar documents
Elena Anatolyevna Katunina, Yu. N. Bezdolnyi, E. A. Malykhina, N. V. Titova
"... Levodopa remains the most effective drug for the treatment of Parkinson's disease. The paper ..."
 
Vol 9, No 3 (2017) Screening for non-motor symptoms in Parkinson's disease using the NMSQuest scale Abstract  similar documents
A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, N. A. Schnaider, M. M. Petrova
"... The clinical picture of Parkinson's disease (PD) includes a wide range of non-motor symptoms (NMS ..."
 
Online-first Association of carriers of single nucleotide polymorphisms rs206787 and rs516535 in gene BRD2 and rs3743123 in gene GJD2 with juvenile myoclonic epilepsy of Caucasian patients in the Siberia Abstract  similar documents
O. S. Shilkina, N. A. Shnayder, S. N. Zobova, D. V. Dmitrenko, P. V. Moskaleva
"... This article outlines recent findings on genetics of juvenile myoclonic epilepsy (JME), where JME ..."
 
Vol 11, No 4 (2019) Association of the carriage of BRD2 rs206787 and rs516535 and GJD2 rs3743123 polymorphisms with juvenile myoclonic epilepsy in Caucasian patients of Siberia Abstract  similar documents
O. S. Shilkina, N. A. Shnayder, S. N. Zobova, D. V. Dmitrenko, P. V. Moskaleva
"... In recent years, the genetics of juvenile myoclonic epilepsy (JME) has been actively studied ..."
 
Vol 11, No 3 (2019) The features of the pathogenesis and clinical picture of Parkinson's disease that has developed in essential tremor Abstract  similar documents
A. V. Kudrevatykh, I. V. Miliukhina
"... In the past decades, there has been evidence on the relationship between Parkinson's disease (PD ..."
 
Vol 7, No 4 (2015) Some aspects of treatment for cognitive impairments. Cyticolin: pharmacological characteristics, possible benefits, aspects of use Abstract  similar documents
N. V. Trofimova, I. S. Preobrazhenskaya
 
Vol 11, No 3 (2019) The use of vortioxetine for the correction of depression in Parkinson's disease: an example of clinical cases Abstract  similar documents
I. V. Miliukhina
"... The prevalence of depression in Parkinson's disease (PD) amounts to as much as 90%. The paper ..."
 
Vol 10, No 4 (2018) Nighttime sleep disorders in patients with daytime sleepiness in Parkinson s disease Abstract  similar documents
M. R. Nodel, K. V. Shevtsova, G. V. Kovrov, N. N. Yakhno
"... Daytime sleepiness is one of the clinically significant non-motor manifestations of Parkinson ..."
 
Vol 3, No 3 (2011) Neuropsychiatrie disorders in Parkinson's disease and their correction with the MAO-B inhibitor rasagiline (Azilect®) Abstract  similar documents
M. R. Nodel
"... Parkinson's disease (PD) is a multisystemic neurodegenerative disease with a broad spectrum ..."
 
Vol 10, No 4 (2018) Impact of stimulating cognitive-motor training on neuropsychological status and quality of life in patients with Parkinson's disease Abstract  similar documents
Yu. N. Bykov, T. B. Bender, Yu. N. Vasiliev, A. N. Kalyagin, Т. М. Maksikova, G. M. Orlova, N. M. Kozlova, O. V. Ryzhkova
"... Motor and non-motor symptoms are identified in the clinical picture of Parkinson's disease (PD ..."
 
Vol 3, No 1 (2011) Heart rhythm variability analysis in patients with Levy body dementia and in those with Parkinson's disease Abstract  similar documents
I. G. Tishkova, I. S. Preobrazhenskaya
"... ) and Parkinson's disease (PD). Objective: to analyze autonomic provision of cardiac performance in patients ..."
 
Vol 11, No 2 (2019) Susceptibility-weighted MR imaging (SWI) of basal ganglia iron deposition in the early and advanced stages of Parkinson's disease Abstract  similar documents
A. G. Trufanov, A. A. Yurin, A. B. Buriak, S. A. Sandalov, M. M. Odinak, I. V. Litvinenko
"... Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer ..."
 
Vol 3, No 4 (2011) Individual functional interhemispheric asymmetry profile and clinical and neurophysiological features in patients with Parkinson's disease Abstract  similar documents
M. A. Bykanova, A. Yu. Kovalchuk, N. V. Pizova, N. G. Efremenko, A. A. Kostylev
"... ) in 70 patients (28 men and 42 women) with Parkinson's disease (PD), by using the examination protocol ..."
 
Vol 10, No 3 (2018) Familial neurodegenerative disease with parkinsonism syndrome and amyotrophic lateral sclerosis Abstract  PDF (Eng)  similar documents
T. K. Davydova, A. A. Tappakhov, T. E. Popova, E. E. Konnikova, A. D. Alekseeva, D. A. Popov
"... siblings, one of whom is observed to have parkinsonism with ALS syndrome; and the other had Parkinson ..."
 
Vol 6, No 2 (2014) A clinical case of SYNGAP1, с2214_2217delTGAG de novo gene mutations in a girl with epilepsy, mental retardation, autism, and movement disorders Abstract  similar documents
M.Yu Bobylova, M.B. Mironov, A.V. Kulikov, M.V Kazakova, M.A. Bogacheva, Yu.A. Tankevich, L.Yu. Glukhova, E.I Barletova, M.O. Abramov, K.Yu. Mukhin, G.E. Rudenskaya
"... The practical introduction of the latest genetic techniques could provide the basis ..."
 
Vol 7, No 3 (2015) Hereditary cerebellar ataxias with polyneuropathy Abstract  similar documents
Svetlana Vasilyevna Kopishinskaya
"... by molecular genetic testing. In recent years, some genetic diseases manifesting themselves by a concurrence ..."
 
Vol 1, No 1 (2009) CONCOMITANCE OF INFANTILE AUTISM AND EPILEPSY: ETIOPATHOGENIC ASPECTS Abstract  similar documents
E. V. Malinina, S. A. Suprun, E. A. Markova
"... on the implication of genetic and organic disorders and epileptiform activity in the origin of these disorders ..."
 
Vol 10, No 1S (2018): СПЕЦВЫПУСК: ЭПИЛЕПСИЯ Unverricht-Lundborg disease in an adult female patient: a clinical case Abstract  similar documents
V. A. Karlov, I. A. Zhidkova, E. Yu. Mishina, P. N. Vlasov, N. V. Margosyuk, L. P. Tingaeva, E. M. Perepelova, V. A. Perepelov, B. P. Gladov, S. A. Trukhanov
"... been long followed up for diagnosed juvenile myoclonic epilepsy); the relative role of a genetic study ..."
 
Vol 5, No 3 (2013) Two cases of Wilson–Konovalov disease Abstract  similar documents
Alla Anatolyevna Strutsenko, V V Golubeva, N V Mazurchik, N I Garabova, N V Nozdryukhina
"... genetic disorder. For its pathogenesis, there is the underlying genetic disorder of copper metabolism ..."
 
Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания Alzheimer's disease Abstract  similar documents
N. N. Koberskaya
"... Despite progress made in laboratory methods, genetic studies, and modern neuroimaging ..."
 
Vol 11, No 3 (2019) Vascular cognitive impairment and Alzheimer's disease: Is there a relationship between them? Abstract  similar documents
G. R. Tabeeva, E. A. Kirjanova
"... manifestations, neuromorphological changes, as well as genetic and neuroimaging biomarkers. The complex ..."
 
Vol 9, No 3 (2017) Current views of the risk factors, diagnosis, and therapy of Alzheimer's disease (according to the proceedings of the Alzheimer's Association International Conference, London, 2017) Abstract  similar documents
N. N. Koberskaya
"... in the elderly. The data of epidemiological and genetic studies and risk factors for AD were considered. Great ..."
 
Vol 4, No 1 (2012) Generalized epilepsies: current conceptions and therapeutic approaches Abstract  similar documents
L R Zenkov
"... epilepsies have been revealed. The closeness of these forms is also supported by genetic studies when one ..."
 
Vol 10, No 4 (2018) Approaches to therapy for depressions in neurology: prospects for the use of agomelatine Abstract  similar documents
D. V. Romanov, B. A. Volel, D. S. Petelin
"... of patients with post-stroke depression, Parkinson’s disease, Alzheimer’s disease, Pick’s disease, Huntington ..."
 
Vol 8, No 1 (2016) Role of lipoprotein (a) in the development of ischemic stroke and other cardiovascular diseases Abstract  similar documents
N. A. Pizov, N. V. Pizova
"... and representatives of other races. There is evidence on the genetic determination and variability of the Apo (a) gene ..."
 
Vol 10, No 4 (2018) Environmental factors and a risk for multiple sclerosis in the Altai Territory Abstract  similar documents
I. P. Saldan, I. V. Smagina, S. A. Elchaninova
"... system, the risk of which depends on genetic and environmental factors. The Altai Territory ..."
 
Vol 10, No 4 (2018) Research Institute of Internal and Preventive Medicine, Branch, Federal Research Center, Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences Abstract  similar documents
A. V. Titarenko, S. V. Shishkin, L. V. Shcherbakova, E. G. Verevkin, M. Holmes, M. Bobak, S. K. Malyutina
 
Vol 4, No 1 (2012) Association of the dopamine receptor (DRD4, DAT) gene polymorphisms with vital exhaustion in an open population among 25—64-year-old men (Novosibirsk): Epidemiological study according to the WHO MONICA-psychosocial program Abstract  similar documents
Valery Vasilyevich Gafarov, M I Voyevoda, E A Gromova, V N Maksimov, A V Gafarova, I V Gagulin, N S Yudin, T M Mishakova
"... in the Laboratory of Molecular Genetic Studies, Therapy Research Institute, Siberian Branch, Russian Academy ..."
 
1 - 70 of 95 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)